Alex Gloor

Popular Topics

Food, Drugs, Healthcare, Life Sciences Intellectual Property

Alex Gloor’s articles from Gowling WLG are most popular:

in China and Asia

DETAILS

Canada

www.gowlingwlg.com

+1 613 2331781

AUTHORS CONTENT

Health Canada And The Public Health Agency Of Canada Report On Red Tape Reduction Measures

Canada Healthcare

Health Canada Proposes To Remove Phase III Trial Requirement From Biosimilar Approval Pathway

Canada Healthcare

Canadian Patent Law: 2024 In Review

Federal Court Of Appeal Addresses Patentability Of Methods Of Medical Treatment In Canada

Canadian Patent Law: 2023 Year In Review

Ontario Superior Court Dismisses Claim For Section 8 Damages

Canadian Patent Law: 2022 Year In Review

Crocs Successfully Asserts Industrial Design, Awarded Infringer's Profits

Promise Me No Promises? The Five-year Anniversary Of The Supreme Court's AstraZeneca Decision

Canadian Patent Law: 2021 Year In Review

Amendments To The Patented Medicines Regulations Delayed Six Months, Until July 1, 2022

Patent Litigation Trends: The Future Of Biologics?

PMPRB Seeks Feedback On Guideline Monitoring And Evaluation Plan

Proposed Amendments To Listing Patents On Canada's Patent Register

Federal Court Of Appeal Dismisses Appeals Brought By Apotex In Respect Of Takeda's Canadian VYVANSE® Patent

Ontario Superior Court Of Justice Dismisses Statute Of Monopolies Action Via Summary Judgment

Second Medical Use Patents Part 2 - Verifying Validity

Second Medical Use Patent Series: Understanding Infringement And Enforcement (Video)

Canadian Patent Law: 2020 Year In Review

Amendments To The Patented Medicines Regulations Delayed By 6-months, Until July 1, 2021

Canada Healthcare

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More